latest news releases from the newsroom
AB Volvo Repurchased 2,410,000 B Shares and 70,000 A Shares During Last Week
GOTEBORG, Sweden, Feb. 21, 2005 (PRIMEZONE) -- Further to the decision taken by AB Volvo's Board of Directors on June 17, 2004, regarding repurchase of own shares, AB Volvo has, during the week February 14-18, acquired a total of 2,410,000 series B shares and 70,000 series A shares.
JetBlue Airways Corporation
JetBlue to Waive Change Fees and Fare Differences to Assist Customers Who May be Affected by Winter Weather in The Northeast
NEW YORK, Feb. 20, 2005 (PRIMEZONE) -- JetBlue Airways (Nasdaq:JBLU) announced today that it will waive its change fee and any fare differences to allow customers who have reservations for travel tomorrow, February 21 to or from New York City's John F. Kennedy International Airport, New York's LaGuardia Airport, Boston, MA; Buffalo, Syracuse, Rochester, NY or Burlington, VT to postpone their plans through Wednesday, February 23 to avoid the winter snowstorm in the area. Customers should call 1-800-JETBLUE (538-2583) to arrange for ticket changes.
Emerson Poynter LLP
Emerson Poynter LLP Files Class Action Suit against Former and Current Officers of Tower Automotive, Inc. -- TWR
LITTLE ROCK, Ark., Feb. 18, 2005 (PRIMEZONE) -- Emerson Poynter LLP (www.emersonpoynter.com), a national law firm with offices in Houston, Little Rock, and Seattle, announced today that it has filed in the United States District Court for the Southern District of New York on behalf of purchasers of Tower Automotive, Inc. ("Tower Automotive") (NYSE:TWR) common stock during the period between February 14, 2003, and January 21, 2005 (the "Class Period").
Murray, Frank & Sailer LLP
Investor Notice: Murray, Frank & Sailer LLP Files Shareholder Class Action Against EPIX Pharmaceuticals, Inc. -- EPIX
NEW YORK, Feb. 18, 2005 (PRIMEZONE) -- Murray, Frank & Sailer LLP announces that it has filed a class action lawsuit in the United States District Court for the District of Massachusetts on behalf of purchasers of the securities of EPIX Pharmaceuticals, Inc. (f/k/a EPIX Medical, Inc.) ("EPIX" or the "Company") (Nasdaq:EPIX) between July 10, 2003 and January 14, 2005, inclusive (the "Class Period").
Discovery Laboratories, Inc.
Discovery Labs to Raise Additional $2.6 Million in Registered Direct Offering
WARRINGTON, Pa., Feb. 18, 2005 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), has announced that in response to additional interest, the previously reported Registered Direct Offering with purchase commitments totaling approximately $26.5 million has been extended to include an additional commitment to purchase approximately $2.6 million of its common stock in a registered direct offering. Under the terms of the additional transaction, Discovery will sell approximately 450,000 shares of its common stock to a select institutional investor. The closing of the offering is expected to take place on February 24, 2005, subject to the satisfaction of customary closing conditions. All of the shares of common stock are being offered by Discovery pursuant to an effective registration statement previously filed with the Securities and Exchange Commission. SG Cowen & Co., LLC acted as exclusive placement agent for the transaction.